Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 478 (CSE: $RAMM.C) (TSX: $APHA.TO) (NASDAQ: $APHA), (OTC: $MJNA)
Today's
podcast sponsored by Cannabis Suisse Corp. (OTC: $CSUI), a fully licensed
cannabis cultivation and distribution company in Switzerland
Delta, Kelowna, BC, October 8, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2020/100820-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/10081RAMM-APHA-MJNA.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on
Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
Today’s podcast is
sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis
cultivation and distribution company in Switzerland, for recreational tobacco
products and medical CBD oils. The Company's facilities for producing cannabis
are based in Dietikon, Switzerland, and contain the art surveillance equipment
to enable an around the clock webcast. Cannabis Suisse grows high quality,
organic cannabis with sustainable, all-natural principles. The Company's
products are laboratory tested to ensure the end users have access to a
standardized, safe and consistent product. Cannabis Suisse proprietary
trademarked MoldStandard is a quantitative microbiology method for analyzing
yeast and mold counts in harvested cannabis plants. Cannabis Suisse proprietary
trademarked CannaMec is a method for quantifying and removing residual solvents
during packaging and storage of CBD products. Cannabis Suisse Corp. currently
sells via a distribution network of Swiss retailers and online shops, under the
retail brand Alpine Cannabis.
In
today’s podcast we look at a few public and private company announcements.
Aphria
Inc. (TSX: APHA) (NASDAQ: APHA), a leading global cannabis
company inspiring and empowering the worldwide community to live their very
best life, announced that it has completed its first
certified European Union Good Manufacturing Practices ("EU GMP")
shipment of dried flower from its Aphria One EU GMP facility to its
wholly-owned German subsidiary, CC Pharma GmbH, a leading distributor of
pharmaceutical products to more than 13,000 pharmacies in Germany.
"Our first EU GMP shipment into
Germany represents another significant milestone for Aphria Inc., one that
strengthens our position as a leading cannabis company in Germany and in the
European Union," said Irwin D. Simon, Chief Executive Officer, Aphria Inc.
"We are leveraging our strong medical platform and multi-faceted German
strategy, which combines domestic cultivation, import licenses and large
distribution infrastructure, to increase access to high-quality medical cannabis
for patients worldwide. We remain excited about future milestones, including
the completion of our cultivation facility in Neumünster, Germany, which we
expect will be completed in Q2 FY2021."
The German market is considered to
be one of the most highly sought-after developed medical cannabis markets in
the world. Aphria's German operations have been preparing for the importation
of EU-GMP certified cannabis from Canada, allowing for shipments to CC Pharma
in order to leverage CC Pharma's expansive in-country distribution network.
Pabst Labs, a newly formed
licensed cannabis company, has revealed the initial launch of Pabst Blue Ribbon
Cannabis Infused Seltzer. The famed Blue Ribbon, synonymous with good times for
over 175 years, will now adorn the can of a non-alcoholic THC infused seltzer
developed by Pabst Labs.
Pabst
Labs was founded by a group of cannabis beverage experts and former Pabst
Brewing Company employees who were granted the rights to create a line of
cannabis infused drinks under the Pabst Blue Ribbon Name. Pabst Labs is
responsible for the production, marketing and sales of the new drink.
“Pabst
Blue Ribbon has an incredibly loyal and passionate customer base who are open
to change and embracing new ideas. We’ve spent a long time creating a quality
product for both new and experienced users, and believe the entry of an
established brand can help kick-start the cannabis drinks category,” said Mark
Faicol, Pabst Labs Brand Manager.
Pabst
Blue Ribbon Cannabis Infused Seltzer marks a major milestone for the burgeoning
cannabis drinks industry, and an awesome way for lovers of Pabst Blue Ribbon to
experiment with a new kind of buzz. The initial test launch will see Pabst Blue
Ribbon Cannabis Infused Seltzer available for customers in a select group of
California dispensaries and direct to California consumers via shop.PabstLabs.com.
Pabst
Labs is thrilled and honored to develop a product that’s fit to use the famed
Pabst Blue Ribbon name. Pabst Blue Ribbon is one of America’s most beloved
brands, a champion of the creative community and lifestyle, and recently has
been innovating beyond beer, with the launches of Hard Coffee, Hard Tea and
Harder Seltzer.
Pabst
Blue Ribbon’s willingness to experiment and push boundaries led Pabst Labs to
enquire about collaborating, and a shared passion for quality and innovation
ultimately led to Pabst Labs being granted the rights to create a line of
cannabis infused drinks worthy of the Blue Ribbon.
Each 12
oz can of Pabst Blue Ribbon Cannabis Infused Seltzer is made from the
highest-quality ingredients and serves up a delicious effervescent
lemon-flavored seltzer that contains just 4 grams of sugar, 25 calories and
contains no preservatives. With 5 mg of THC per can Pabst Labs has ensured it
offers up a responsible dosage designed to make it a go to drink for both
casual and experienced cannabis users. The lemon seltzer will be the only
flavor available during initial launch, but additional flavors are already in
development.
“Though
this is a limited initial launch, we’ve had a really enthusiastic and positive
response from dispensaries and customers, and are looking forward to a wider
roll out in the coming months. For over 175 years the Blue Ribbon has connected
fans across generations around its products, and we think customers, new and
old, are going to love the chance to experiment with something different from a
brand they trust,” concluded Faicol.
RAMM
Pharma Corp. (CSE: RAMM), a leader in plant-derived
cannabinoid pharmaceutical products, announced that the Company has commenced sales
of its Epifractán™ products through Peruvian pharmacies. As announced on July 9th
and 16th, 2020, Epifractán™ was approved and registered by Peru’s
Ministry of Health (Ministerio de Salud or “MINSA”), becoming one of only a few
cannabis products registered in the country. Both Epifractán™ 2% and
Epifractán™ 5% have now been shipped to Peru for sale through pharmacies and
will be available to patients with a medical prescription.
RAMM also continues to scale up
regular shipments of Epifractán™ to Brazil under the country’s compassionate
use framework.
“Sales of our registered medical
products through pharmacies is significant to expanding their accessibility to
patients in new markets,” stated Jack Burnett, Chief Executive Officer.
Epifractán™ was approved and
registered in Peru upon the completion of rigorous testing requirements and
approval by MINSA to certify consistency, stability and effective shelf life.
Registered products are available at pharmacies as branded finished products
and should not be confused with magistral formulas which are prepared by a
pharmacist on a case-by-case basis and have not received MINSA approval and
registration. Currently only very few cannabidiol products have been granted
MINSA registration in Peru.
Medical
Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded
cannabis company in the United States that launched the world’s first-ever
cannabis-derived nutraceutical products, brands and supply chain, announced today that Raul Elizalde, the co-CEO
of subsidiary HempMeds®, was featured in global financial news outlet Reuters
discussing the future of Mexico’s legal cannabis industry.
The October 1, 2020, Reuters article
entitled “Mexico, plagued by cartel wars, on cusp of legal cannabis
'green rush'” provided coverage on pending legislation in Mexico
that would make the country legal for both medicinal and recreational use.
Though HempMeds® is listed in the article as a large player that is looking to
get involved in these new markets, the Company has been operating and selling
high-quality cannabidiol (CBD) products there for the past four years and was
the first to legally import CBD to consumers in Mexico under a federal
government import permit in 2016.
“We’ve made great progress in Latin
America, specifically Mexico and Brazil, and are excited to see how different
Mexico’s legal cannabis market looks in just a few short months,” said Medical
Marijuana, Inc. CEO Dr. Stuart Titus. “We will continue to offer the
highest-quality products and look forward to finding new ways to expand our
footprint and offerings in Mexico.”
According to the article, there may
soon be a huge influx of large U.S. and Canadian cannabis companies breaking
into Mexico’s legal cannabis market, as well as local entrepreneurs who want to
get involved. Though there is a long history of Mexico’s drug cartel influence,
with these new laws the country would be able to fuel legal cannabis businesses
selling in privately run sales and distribution centers.
Once again, today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts
and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech,
water, renewable energy and more. Investor Idea’s original branded content
includes the following podcasts and columns : Crypto
Corner , Play by Play sports and stock news column, Investor
Ideas Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
https://www.investorideas.com/About/Private_Policy.asp
Disclosure: Cannabis Suisse Corp. (OTC: CSUI ),is a paid featured company on
Investorideas.com
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor
Ideas – news, articles, podcasts and stock
directory
No comments:
Post a Comment